Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

Similar articles for PubMed (Select 22546091)

1.

Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation.

Schellenberg AE, Buist R, Del Bigio MR, Toft-Hansen H, Khorooshi R, Owens T, Peeling J.

Fluids Barriers CNS. 2012 Apr 30;9(1):10. doi: 10.1186/2045-8118-9-10.

2.

Metalloproteinases control brain inflammation induced by pertussis toxin in mice overexpressing the chemokine CCL2 in the central nervous system.

Toft-Hansen H, Buist R, Sun XJ, Schellenberg A, Peeling J, Owens T.

J Immunol. 2006 Nov 15;177(10):7242-9.

3.

Expression of astrocytic type 2 angiotensin receptor in central nervous system inflammation correlates with blood-brain barrier breakdown.

Füchtbauer L, Toft-Hansen H, Khorooshi R, Owens T.

J Mol Neurosci. 2010 Sep;42(1):89-98. doi: 10.1007/s12031-010-9371-8. Epub 2010 Apr 23.

PMID:
20414743
4.

Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?

Feng S, Huang Y, Chen Z.

Med Hypotheses. 2011 May;76(5):618-21. doi: 10.1016/j.mehy.2010.12.001. Epub 2011 Mar 12.

PMID:
21398042
5.

Glia-induced reversible disruption of blood-brain barrier integrity and neuropathological response of the neurovascular unit.

Willis CL.

Toxicol Pathol. 2011 Jan;39(1):172-85. doi: 10.1177/0192623310385830. Epub 2010 Dec 28.

6.

Induction of blood brain barrier tight junction protein alterations by CD8 T cells.

Suidan GL, Mcdole JR, Chen Y, Pirko I, Johnson AJ.

PLoS One. 2008 Aug 22;3(8):e3037. doi: 10.1371/journal.pone.0003037.

7.

Investigation of blood-brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in rats.

Rousseau V, Denizot B, Pouliquen D, Jallet P, Le Jeune JJ.

MAGMA. 1997 Sep;5(3):213-22.

PMID:
9351025
8.

Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: a future therapeutic target for treatment of stroke.

Jin AY, Tuor UI, Rushforth D, Kaur J, Muller RN, Petterson JL, Boutry S, Barber PA.

BMC Neurosci. 2010 Feb 2;11:12. doi: 10.1186/1471-2202-11-12.

9.

Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.

Bennett J, Basivireddy J, Kollar A, Biron KE, Reickmann P, Jefferies WA, McQuaid S.

J Neuroimmunol. 2010 Dec 15;229(1-2):180-91. doi: 10.1016/j.jneuroim.2010.08.011. Epub 2010 Sep 15.

PMID:
20832870
10.

Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.

Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV.

J Cereb Blood Flow Metab. 2006 Jun;26(6):797-810.

PMID:
16192992
11.

Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.

Ladewig G, Jestaedt L, Misselwitz B, Solymosi L, Toyka K, Bendszus M, Stoll G.

Exp Neurol. 2009 Nov;220(1):207-11. doi: 10.1016/j.expneurol.2009.08.027. Epub 2009 Sep 4.

PMID:
19733560
12.

Magnetic resonance imaging to assess blood-brain barrier damage in murine trypanosomiasis.

Rodgers J, McCabe C, Gettinby G, Bradley B, Condon B, Kennedy PG.

Am J Trop Med Hyg. 2011 Feb;84(2):344-50. doi: 10.4269/ajtmh.2011.10-0487.

13.

Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.

Nico B, Frigeri A, Nicchia GP, Corsi P, Ribatti D, Quondamatteo F, Herken R, Girolamo F, Marzullo A, Svelto M, Roncali L.

Glia. 2003 May;42(3):235-51.

PMID:
12673830
14.
15.

Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.

Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Van Rooijen N, Andjelkovic AV.

J Cereb Blood Flow Metab. 2005 May;25(5):593-606.

PMID:
15689955
16.

Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles: usefulness for distinguishing between focused ultrasound-induced blood-brain barrier disruption and brain hemorrhage.

Liu HL, Hsu PH, Chu PC, Wai YY, Chen JC, Shen CR, Yen TC, Wang JJ.

J Magn Reson Imaging. 2009 Jan;29(1):31-8. doi: 10.1002/jmri.21599.

PMID:
19097103
17.

Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: correlation with minocycline administration as a therapeutic agent.

Mishra MK, Dutta K, Saheb SK, Basu A.

Neurochem Int. 2009 Dec;55(8):717-23. doi: 10.1016/j.neuint.2009.07.006. Epub 2009 Jul 21.

PMID:
19628016
18.

Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.

Hartz AM, Bauer B, Soldner EL, Wolf A, Boy S, Backhaus R, Mihaljevic I, Bogdahn U, Klünemann HH, Schuierer G, Schlachetzki F.

Stroke. 2012 Feb;43(2):514-23. doi: 10.1161/STROKEAHA.111.627562. Epub 2011 Nov 23.

19.

Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis.

Hoffman WH, Stamatovic SM, Andjelkovic AV.

Brain Res. 2009 Feb 13;1254:138-48. doi: 10.1016/j.brainres.2008.11.100. Epub 2008 Dec 11.

PMID:
19103180
20.

Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice.

Huang D, Tani M, Wang J, Han Y, He TT, Weaver J, Charo IF, Tuohy VK, Rollins BJ, Ransohoff RM.

J Neurosci. 2002 Dec 15;22(24):10633-42.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk